Recent News

• 04.30.2025 - GeneDx First Quarter 2025 Earnings Conference Call
• 04.25.2025 - A breakthrough in autism research: 230 new genes now associated with autism.
• 04.16.2025 - GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale
• 04.08.2025 - GeneDx to Report First Quarter 2025 Financial Results on Wednesday, April 30, 2025
• 04.03.2025 - GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication
• 03.26.2025 - When a cerebral palsy diagnosis isn’t diagnosis enough: How one mom’s tenacity got her daughter exome testing—and answers
• 03.20.2025 - GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.18.2025 - Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies

Recent Filings

• 04.16.2025 - 8-K Current report
• 04.16.2025 - EX-99.1 EX-99.1
• 04.14.2025 - 144 Report of proposed sale of securities
• 04.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.09.2025 - 144 Report of proposed sale of securities
• 04.09.2025 - 144 Report of proposed sale of securities
• 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.26.2025 - 144 Report of proposed sale of securities